LCN2 and chronic kidney disease: The aim of this study was to assess the effect of the reduction of GFR on plasma BNP and plasma and urinary NGAL and, for comparison, on serum and urinary concentrations of low-molecular-weight proteins (LMWPs) and urinary activity of tubular enzymes in stable CKD patients at different functional stages.